Phio Pharmaceuticals Corp. Underwriting Agreements
7 Contracts & Agreements
- Underwriting Agreement, dated as of February 11, 2020, between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein (Filed With SEC on February 13, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 31, 2020)
- Underwriting Agreement, dated as of October 1, 2018, between RXi Pharmaceuticals Corporation and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein (Filed With SEC on October 5, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 28, 2018)
- 2,131,111 SHARES OF COMMON STOCK, 8,082 SHARES OF SERIES B CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO 8,980,000 SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR 11,111,111... (Filed With SEC on December 19, 2016)
- SHARES OF COMMON STOCK, SHARES OF SERIES BCONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR SHARES OFCOMMON STOCK) OF RXi... (Filed With SEC on December 14, 2016)
- SHARES OF COMMON STOCK, SHARES OF SERIES BCONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR SHARES OFCOMMON STOCK) OF RXi... (Filed With SEC on November 30, 2016)
